P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000970384.26808.c7 |
| _version_ | 1827331877039505408 |
|---|---|
| author | Salomon Manier Alexander Lesokhin Mohamad Mohty Ruben Niesvizky Christopher Maisel Bertrand Arnulf Sarah M. Larson Asya Nina Varshavsky-Yanovsky Xavier Leleu Lionel Karlin David H. Vesole Nizar J Bahlis Carlos Fernandez de Larrea Noopur Raje Eric Leip Sharon T. Sullivan Mohamed Elmeliegy Andrea Viqueira Ajay Nooka |
| author_facet | Salomon Manier Alexander Lesokhin Mohamad Mohty Ruben Niesvizky Christopher Maisel Bertrand Arnulf Sarah M. Larson Asya Nina Varshavsky-Yanovsky Xavier Leleu Lionel Karlin David H. Vesole Nizar J Bahlis Carlos Fernandez de Larrea Noopur Raje Eric Leip Sharon T. Sullivan Mohamed Elmeliegy Andrea Viqueira Ajay Nooka |
| author_sort | Salomon Manier |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:46:44Z |
| format | Article |
| id | doaj.art-ec2cb963cbdf4122a04e16213f7611e7 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:46:44Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-ec2cb963cbdf4122a04e16213f7611e72024-03-03T06:25:15ZengWileyHemaSphere2572-92412023-08-017e26808c710.1097/01.HS9.0000970384.26808.c7202308003-00770P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIESSalomon Manier0Alexander Lesokhin1Mohamad Mohty2Ruben Niesvizky3Christopher Maisel4Bertrand Arnulf5Sarah M. Larson6Asya Nina Varshavsky-Yanovsky7Xavier Leleu8Lionel Karlin9David H. Vesole10Nizar J Bahlis11Carlos Fernandez de Larrea12Noopur Raje13Eric Leip14Sharon T. Sullivan15Mohamed Elmeliegy16Andrea Viqueira17Ajay Nooka181 Lille University Hospital, Lille, France2 Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College, New York, United States3 Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France4 Weill Cornell Medical College - New York Presbyterian Hospital, New York, United States5 Baylor University Medical Center, Dallas, United States6 Hôpital Saint-Louis, Paris, France7 University of California Los Angeles Medical Center, Los Angeles, United States8 Fox Chase Cancer Center, Philadelphia, United States9 Centre Hospitalier Universitaire de Poitiers, Poitiers, France10 Centre Hospitalier Lyon, Lyon, France11 John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, United States12 Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada13 Hospital Clinic de Barcelona, Barcelona, Spain14 Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, United States15 Pfizer Inc, Cambridge, United States15 Pfizer Inc, Cambridge, United States16 Pfizer Inc., San Diego, United States17 Pfizer SLU, Madrid, Spain18 Winship Cancer Institute, Atlanta, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000970384.26808.c7 |
| spellingShingle | Salomon Manier Alexander Lesokhin Mohamad Mohty Ruben Niesvizky Christopher Maisel Bertrand Arnulf Sarah M. Larson Asya Nina Varshavsky-Yanovsky Xavier Leleu Lionel Karlin David H. Vesole Nizar J Bahlis Carlos Fernandez de Larrea Noopur Raje Eric Leip Sharon T. Sullivan Mohamed Elmeliegy Andrea Viqueira Ajay Nooka P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES HemaSphere |
| title | P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
| title_full | P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
| title_fullStr | P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
| title_full_unstemmed | P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
| title_short | P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
| title_sort | p870 efficacy and safety of elranatamab in patients with relapsed refractory multiple myeloma and prior b cell maturation antigen bcma directed therapies a pooled analysis from magnetismm studies |
| url | http://journals.lww.com/10.1097/01.HS9.0000970384.26808.c7 |
| work_keys_str_mv | AT salomonmanier p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT alexanderlesokhin p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT mohamadmohty p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT rubenniesvizky p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT christophermaisel p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT bertrandarnulf p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT sarahmlarson p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT asyaninavarshavskyyanovsky p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT xavierleleu p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT lionelkarlin p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT davidhvesole p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT nizarjbahlis p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT carlosfernandezdelarrea p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT noopurraje p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT ericleip p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT sharontsullivan p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT mohamedelmeliegy p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT andreaviqueira p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT ajaynooka p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies |